Umbilical Cord Blood Transplant (UCBT) Is an Attractive Option for Patients with Non-Malignant Diseases; A CIBMTR Report.

Key Points

• Umbilical cord blood transplant demonstrates potential benefits for patients with non-malignant diseases, enhancing treatment prospects.
• Over 1000 patients received umbilical cord blood transplant, showing positive outcomes across various conditions.
• CIBMTR analysis of transplant records provides insights into treatment efficacy and patient survival rates.
• These findings suggest umbilical cord blood transplant may be a significant option for alternative therapies in diverse patient populations.